U.S.-based Vertex Pharmaceuticals (VRTX) has secured approval from the FDA (Food and Drug Administration) for its ...

BMO Capital analyst Evan Seigerman raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $520 and keeps an Outperform ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

The VERTEX 80/80v spectrometers are provided with five beam exit ports and two beam input ports and offer the possibility to connect them, for instance, to external laser and synchrotron light ...

This function displays the lens distortion of glasses being used by the customer by obtaining the vertex power difference ... the transmittance of visible light by using the Green light source.

A blue, gold and white logo has been revealed for the Tennessee Summitt in Nashville's WNBA expansion team bid.

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $440.68, marking a -0.72% move from the previous day. Vertex (VRTX) has received quite a bit of attention from Zacks.com ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

This kit doesn't include the RPi CM4 module. All-in-one Mini-Computer, mainly designed for home or small home office, but not limited to the above applications Built-in 2xSATA slots for installing ...

Erik Kain is a writer and critic covering TV shows, movies, video games and books primarily in the "genre" category including fantasy, science-fiction, mysteries, thrillers, post-apocalytpic ...